RxDoctor Payments Data

Paige Sullivan

Physician Assistant · Utica, NYNPI 1649808411

Payments from drug & device makers

$5,681in general payments, 2019–2025

Across 246 payments — averaging $23.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AOP Health US, LLC$1K
  • E.r. Squibb & Sons, L.L.C.$536
  • Novartis$525
  • Boehringer Ingelheim$486
  • Amgen$419
  • Abiomed$394
  • plus $2K from 25 others

What the payments were for

  • Food & beverage$5,681100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,681 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$62,673
Medicare patients
534
Services billed
763

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban167$187,671
EntrestoSacubitril/Valsartan101$112,129
XareltoRivaroxaban62$69,354
BrilintaTicagrelor58$52,367
JardianceEmpagliflozin22$31,686
Repatha SureclickEvolocumab20$25,522
Metoprolol Succinate383$6,675
Ranolazine ErRanolazine35$3,591
Rosuvastatin Calcium160$2,423
Atorvastatin Calcium189$1,914
Diltiazem 24hr Er (Cd)Diltiazem Hcl20$1,418
Bisoprolol Fumarate70$1,409
Torsemide59$1,355
Losartan Potassium134$1,134
ClopidogrelClopidogrel Bisulfate126$1,020

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$362$187,671167 claims
NovartisEntresto$525$112,129101 claims
Johnson & JohnsonXarelto$155$69,35462 claims
AstraZenecaBrilinta$313$52,36758 claims
Boehringer IngelheimJardiance$486$31,68622 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Utica

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →